IMAX Résultats passés
Passé contrôle des critères 3/6
IMAX a connu une croissance annuelle moyenne de ses bénéfices de 73.7%, tandis que le secteur Entertainment a vu ses bénéfices augmenter de en hausse à 26.1% par an. Les revenus ont augmenté de en hausse à un taux moyen de 13% par an. Le rendement des capitaux propres de IMAX est 10.1% et ses marges nettes sont de 9.1%.
Informations clés
73.71%
Taux de croissance des bénéfices
73.02%
Taux de croissance du BPA
| Entertainment Croissance de l'industrie | 18.06% |
| Taux de croissance des recettes | 12.96% |
| Rendement des fonds propres | 10.14% |
| Marge nette | 9.08% |
| Dernière mise à jour des bénéfices | 31 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour du récit • Jun 01
IMAX: Premium Formats And Potential Sale Interest Will Drive Future Upside
Analysts have nudged their implied fair value estimate for IMAX higher from about $45.27 to $46.82, citing expectations for stronger revenue growth, higher forecast margins, and recent Street research that highlights potential corporate interest in the company. Analyst Commentary Recent Street research around IMAX reflects an active debate on valuation, execution, and potential corporate interest in the company.Seeking Alpha • May 27
IMAX: Price Surge In Line With Buyout Expectations, But It's Not Pure Roses
Summary IMAX Corporation faces inflation-driven headwinds, but its diversified, quality-focused business model and digital adaptability provide resilience. Q1 2026 revenue declined 6% YoY to $81.38M, with operating margin dropping to 12.2% amid rising costs and softer demand. IMAX’s strategic partnerships with streaming platforms and customizable theater offerings help maintain demand and mitigate competitive and inflationary pressures. With $146M in cash, IMAX’s liquidity remains robust, but at ~$40 per share, valuation appears rich and already prices in potential buyout premiums. Read the full article on Seeking Alpha
Mise à jour du récit • May 02
IMAX: Global Premium Footprint Expansion Will Shape Future Earnings Power
The analyst price target for IMAX edges higher to about $41.09 from $41.00 as analysts incorporate mixed target moves across firms, modest adjustments to revenue growth and margin assumptions, and slightly higher future P/E expectations. Analyst Commentary Recent Street research on IMAX presents a mixed picture, with several firms lifting price targets while a smaller group trims expectations and highlights areas of risk.Mise à jour du récit • Apr 18
IMAX: Premium Theatrical Formats And Strong Box Office Will Drive Future Upside
The IMAX analyst price target edges higher to about $45.27 from $45.00, as analysts factor in recent target raises tied to strong Q4 results, higher box office activity, robust system installs, and expectations for continued importance within the global theatrical ecosystem. Analyst Commentary Recent Street research on IMAX clusters around higher price targets and generally positive reactions to the latest quarterly results, box office trends, and system installation activity.Mise à jour du récit • Apr 04
IMAX: Future Earnings Base And Global Footprint Frame Balanced Opportunity And Risk
Narrative Update: IMAX Analyst Price Target Shift The analyst price target for IMAX has moved to $41.00. Analysts cite record share gains, accelerating international expansion, strong Q4 and full-year revenue and margins, and continued outperformance versus consensus as key factors influencing their updated views.Mise à jour du récit • Mar 21
IMAX: Record Box Office And Premium Format Position Will Support Future Upside
The analyst price target for IMAX is raised by about $1 to $45.00, as analysts factor in higher margin expectations, a lower assumed future P/E multiple, and recent research citing strong quarterly results, record box office driven revenue, and a stronger position in the global theatrical ecosystem. Analyst Commentary Recent research updates show a cluster of target price increases for IMAX, with analysts reacting to reported results, box office trends, and the company’s role in premium theatrical formats.Mise à jour du récit • Mar 06
IMAX: Future Earnings Base And International Footprint Suggest Balanced Opportunity And Risk
The Analyst Price Target for IMAX has increased from $22.04 to $41.00. This reflects analysts' views that recent record revenue, strong margins, higher box office activity and an expanding international footprint support a higher assumed profit margin and P/E multiple in updated models.
Mise à jour du récit • Feb 20
IMAX: Live Sports And Content Partnerships Will Support Future Upside
Analysts have maintained their $47.00 price target on IMAX, citing updated assumptions around discount rate, revenue growth, profit margin, and a higher future P/E multiple. They also highlight broader sector risks such as high development costs, dependence on single assets, and limited near term catalysts in comparable coverage.Mise à jour du récit • Feb 05
IMAX: Future Slate And Execution Will Support Expanded Premium Format Opportunities
Analysts have inched their price target for IMAX higher to approximately US$44.09 from about US$43.73, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. Analyst Commentary Analysts have updated their IMAX models around revenue, margins and future P/E levels, which feeds directly into the small lift in the price target to about US$44.09.Mise à jour du récit • Jan 22
IMAX: Future Slate And Profit Execution Will Support Measured Upside Potential
Analysts have lifted their IMAX fair value estimate from about US$38.81 to roughly US$43.73 per share, citing updated assumptions for revenue growth, profit margins and a lower future P/E that together support a higher price target. Analyst Commentary Analysts reviewing IMAX after the updated fair value estimate are split between what could support the higher valuation and what might limit upside if execution falls short.Mise à jour du récit • Jan 08
IMAX: Premium Screens And Local Language Hits Will Support Future Upside
Analysts have raised their price target on IMAX to $40 from $36, citing record Q3 global box office results, an increasing market share, strong local language titles, and faster-than-expected network expansion in markets with above-average revenue per screen. Analyst Commentary Bullish analysts point to IMAX's recent record Q3 global box office results and its second highest quarterly gross as key supports for their updated views, highlighting what they see as solid execution across the business.Mise à jour du récit • Dec 21
IMAX: Expanding Premium Network Will Drive Stronger Box Office Performance
Analysts have lifted their price target on IMAX to approximately $47 from about $38, citing accelerating network expansion into higher revenue markets, record and resilient box office performance, and an expectation for stronger, more profitable growth that, in their view, supports a lower forward earnings multiple versus historical levels. Analyst Commentary Bullish analysts have recently highlighted IMAX as one of the stronger execution stories in the theatrical ecosystem, pointing to a mix of box office outperformance, premium market exposure, and disciplined capital deployment as key supports for higher valuation.Mise à jour du récit • Dec 07
IMAX: Future Slate And Premium Screen Expansion Will Drive Measured Performance
We raise our IMAX price target to approximately $39 from about $37, as analysts highlight record Q3 box office performance, accelerating high value screen expansion, and a robust Q4 film slate that together support modestly stronger growth and valuation assumptions. Analyst Commentary Recent Street commentary on IMAX has tilted clearly positive, with multiple firms raising price targets in response to stronger than expected operating trends and an improving growth outlook.Mise à jour du récit • Nov 22
IMAX: Future Box Office Releases And Network Expansion Will Shape Performance
IMAX's analyst price target has increased significantly, rising from $36 to $37 per share to $40 to $42 per share, as analysts cite strong quarterly box office results, ongoing network expansion, and promising upcoming film releases as key drivers of growth. Analyst Commentary Recent updates from street research provide insights into the positive momentum behind IMAX's upgraded price targets, as well as areas of continued scrutiny among analysts.Mise à jour du récit • Nov 01
IMAX: Accelerating Network Expansion Will Drive Global Box Office Performance
The analyst consensus price target for IMAX has increased from approximately $36.45 to $37.18. Analysts highlight strong box office performance and accelerating network expansion as key drivers for the upward revision.Mise à jour du récit • Oct 18
North America And Japan Installations Will Strengthen Premium Entertainment
Analysts have raised their price target for IMAX from approximately $34.36 to $36.45. They cite stronger box office performance, accelerating network expansion, and improved margins as key factors supporting the higher valuation.Mise à jour du récit • Oct 04
North America And Japan Installations Will Strengthen Premium Entertainment
IMAX's analyst price target has been raised from $31 to $38, reflecting higher expected margins and valuation multiples according to analysts. Analyst Commentary Analyst sentiment toward IMAX has recently shifted, leading to an upward revision of the company's price target.Article d’analyse • Sep 09
Earnings Tell The Story For IMAX Corporation (NYSE:IMAX) As Its Stock Soars 25%
IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Article d’analyse • Aug 04
Is Now An Opportune Moment To Examine IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), is not the largest company out there, but it received a lot of attention from a...Article d’analyse • Jun 13
An Intrinsic Calculation For IMAX Corporation (NYSE:IMAX) Suggests It's 32% Undervalued
Key Insights IMAX's estimated fair value is US$42.15 based on 2 Stage Free Cash Flow to Equity Current share price of...Article d’analyse • May 17
Market Participants Recognise IMAX Corporation's (NYSE:IMAX) Earnings Pushing Shares 25% Higher
IMAX Corporation ( NYSE:IMAX ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Article d’analyse • May 02
IMAX's (NYSE:IMAX) Soft Earnings Are Actually Better Than They Appear
Shareholders appeared unconcerned with IMAX Corporation's ( NYSE:IMAX ) lackluster earnings report last week. We think...Article d’analyse • Apr 19
Should You Investigate IMAX Corporation (NYSE:IMAX) At US$22.45?
While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it saw significant share price...Article d’analyse • Apr 04
Here's What's Concerning About IMAX's (NYSE:IMAX) Returns On Capital
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Article d’analyse • Mar 15
We Think IMAX (NYSE:IMAX) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Seeking Alpha • Mar 09
IMAX Corporation: Unlocking Asymmetric Gains In Premium Cinema
Summary IMAX remains the leading choice for premium cinema experiences, generating outsized box office returns despite a small footprint of 1% of total screens. The company’s success in China is encouraging, but future box office results may be dampened due to a lack of new local content. IMAX’s global expansion in local language partnerships could face higher costs and challenges adapting to diverse filmmaking workflows. While financially recovered from the pandemic, IMAX’s growth trajectory appears plateaued, with flat revenue and cash flow projections. Given the overvaluation of IMAX stock, investors should hold and wait for a significant price retracement before considering entry. Read the full article on Seeking AlphaArticle d’analyse • Jan 08
Is Now The Time To Look At Buying IMAX Corporation (NYSE:IMAX)?
While IMAX Corporation ( NYSE:IMAX ) might not have the largest market cap around , it led the NYSE gainers with a...Seeking Alpha • Dec 24
IMAX Corporation: Overseas Growth Opportunities
Summary IMAX Corporation's stock has surged 60% since its June lows, but there has been a notable uptick in insider selling in December. IMAX Corporation has considerable long-term growth opportunities and should benefit from an expected well-received movie slate in 2025. An analysis of IMAX Corporation follows in the paragraphs below. Read the full article on Seeking AlphaArticle d’analyse • Dec 10
IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Article d’analyse • Nov 23
IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate
Key Insights IMAX's estimated fair value is US$45.02 based on 2 Stage Free Cash Flow to Equity IMAX's US$25.19 share...Article d’analyse • Nov 07
After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar
The IMAX Corporation ( NYSE:IMAX ) share price has done very well over the last month, posting an excellent gain of...Article d’analyse • Oct 31
Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d’analyse • Oct 13
If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Seeking Alpha • Oct 10
IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential
Summary IMAX Corporation has a long growth runway in international markets, as the foreign markets' IMAX theater network penetration rate is lower than that for the US. IMAX can achieve higher profit margins in the future with rising top line contribution from alternative content that boosts the company's overall capacity utilization rate. IMAX stock is trading at below 1 times PEG, which implies that it is undervalued relative to its financial improvement potential. Read the full article on Seeking AlphaArticle d’analyse • Sep 30
When Should You Buy IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it received a lot of attention from a substantial...
Nouveau récit • Sep 24
Calculated Global Expansion And Innovative Content Slate Set To Propel Growth
IMAX's strategic expansions and landmark deals in global markets promise substantial revenue growth through new installations and high-profile film releases.Article d’analyse • Aug 23
Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture
Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...Seeking Alpha • Jul 30
IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings
Summary IMAX Corporation provides technology to movie theaters bringing an immersive experience, in part protecting the company from the rise of digital streaming platforms. After consistent backlog declines, IMAX finally reported great new signings in Q2, providing a great midterm growth outlook with a great new blockbuster movie pipeline. While IMAX's midterm growth outlook is great, the stock already prices in good growth, mitigating a very significant investment opportunity from the upbeat outlook. Read the full article on Seeking AlphaArticle d’analyse • Jul 26
Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now
When you see that almost half of the companies in the Entertainment industry in the United States have price-to-sales...Article d’analyse • Jun 19
Is IMAX (NYSE:IMAX) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • May 22
Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?
IMAX Corporation ( NYSE:IMAX ), might not be a large cap stock, but it saw a decent share price growth of 18% on the...Seeking Alpha • Apr 08
IMAX Corporation: Good Reasons To Be Bullish
Summary IMAX Corporation's short-to-medium term performance is expected to be good, as the company is grabbing a bigger slice of the global box office and gaining recognition from the film industry's players. For the long term, IMAX is actively diversifying into non-film content like events and documentaries to reduce its reliance on movies over time. I view IMAX stock as a good investment candidate, as there are multiple positive factors for the shares. Read the full article on Seeking AlphaVentilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment IMAX gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 26 | 405 | 37 | 138 | 6 |
| 31 Dec 25 | 410 | 35 | 139 | 6 |
| 30 Sep 25 | 378 | 40 | 136 | 6 |
| 30 Jun 25 | 362 | 33 | 132 | 4 |
| 31 Mar 25 | 360 | 25 | 134 | 4 |
| 31 Dec 24 | 352 | 26 | 132 | 5 |
| 30 Sep 24 | 346 | 23 | 132 | 7 |
| 30 Jun 24 | 358 | 21 | 138 | 10 |
| 31 Mar 24 | 367 | 26 | 140 | 10 |
| 31 Dec 23 | 375 | 25 | 147 | 10 |
| 30 Sep 23 | 387 | 25 | 150 | 9 |
| 30 Jun 23 | 352 | 4 | 147 | 7 |
| 31 Mar 23 | 328 | -7 | 144 | 6 |
| 31 Dec 22 | 301 | -23 | 147 | 5 |
| 30 Sep 22 | 311 | -15 | 148 | 5 |
| 30 Jun 22 | 299 | -15 | 136 | 6 |
| 31 Mar 22 | 276 | -21 | 129 | 7 |
| 31 Dec 21 | 255 | -22 | 117 | 7 |
| 30 Sep 21 | 202 | -54 | 108 | 7 |
| 30 Jun 21 | 183 | -93 | 116 | 6 |
| 31 Mar 21 | 141 | -109 | 120 | 5 |
| 31 Dec 20 | 137 | -144 | 134 | 6 |
| 30 Sep 20 | 205 | -104 | 139 | 6 |
| 30 Jun 20 | 254 | -48 | 138 | 6 |
| 31 Mar 20 | 350 | -11 | 137 | 6 |
| 31 Dec 19 | 396 | 47 | 127 | 5 |
| 30 Sep 19 | 380 | 30 | 124 | 6 |
| 30 Jun 19 | 376 | 26 | 122 | 9 |
| 31 Mar 19 | 370 | 23 | 121 | 11 |
| 31 Dec 18 | 374 | 23 | 121 | 14 |
| 30 Sep 18 | 391 | 26 | 115 | 18 |
| 30 Jun 18 | 408 | 20 | 113 | 18 |
| 31 Mar 18 | 397 | 11 | 110 | 20 |
| 31 Dec 17 | 381 | 2 | 113 | 21 |
| 30 Sep 17 | 362 | 6 | 120 | 19 |
| 30 Jun 17 | 349 | 10 | 124 | 19 |
| 31 Mar 17 | 353 | 18 | 128 | 17 |
| 31 Dec 16 | 376 | 29 | 126 | 16 |
| 30 Sep 16 | 389 | 42 | 126 | 15 |
| 30 Jun 16 | 388 | 48 | 121 | 13 |
| 31 Mar 16 | 404 | 66 | 117 | 12 |
| 31 Dec 15 | 374 | 55 | 116 | 13 |
| 30 Sep 15 | 357 | 53 | 108 | 14 |
| 30 Jun 15 | 332 | 50 | 106 | 16 |
Des revenus de qualité: IMAX a un important ponctuel perte de $26.2M impactant ses 12 derniers mois de résultats financiers à 31st March, 2026.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de IMAX sont plus élevées que l'année dernière IMAX. (9.1%) sont plus élevées que l'année dernière (7%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: IMAX est devenue rentable au cours des 5 dernières années, augmentant ses bénéfices de 73.7% par an.
Accélération de la croissance: La croissance des bénéfices de IMAX au cours de l'année écoulée ( 46.4% ) est inférieure à sa moyenne sur 5 ans ( 73.7% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices IMAX au cours de l'année écoulée ( 46.4% ) a dépassé celle du secteur Entertainment -2%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de IMAX ( 10.1% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/06/02 03:39 |
| Cours de l'action en fin de journée | 2026/06/02 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
IMAX Corporation est couverte par 20 analystes. 11 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Marla Backer | Ascendiant Capital Markets LLC |
| David McFadgen | ATB Cormark Historical (Cormark Securities) |
| Patrick Sholl | Barrington Research Associates, Inc. |